1. Home >
  2. Companies >
  3. Acquired >
  4. Life Science >
  5. United States >
  6. Tennessee >
  7. King Pharmaceuticals >
  8. M&A

King Pharmaceuticals Mergers & Acquisitions

King Pharmaceuticals M&A Summary

King Pharmaceuticals has acquired 2 companies of its own.

King Pharmaceuticals’ largest acquisition to date was in 2008, when it acquired Alpharma Pharmaceuticals for $16.0B. King Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 1

King Pharmaceuticals LLC

501 Fifth Street,
Bristol, Tennessee 37620
United States,
(423) 989-8000
www.kingpharm.com

All (2) Buy (2) Sell (-)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2008-12-29 Alpharma Pharmaceuticals Inc. · Life Science
Piscataway, New Jersey

Alpharma Pharmaceuticals Inc. engages in the manufacturing of pharmaceutical products.

Advisor: BofA Securities 		16,000 Add-on Acquisition

King Pharmaceuticals LLC
Advisor: Credit Suisse Investment Banking

-

Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal